Know Cancer

or
forgot password

Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients


N/A
18 Years
N/A
Open (Enrolling)
Both
Insomnia, Cancer

Thank you

Trial Information

Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients


Inclusion Criteria:



- Meets clinical criteria for insomnia.

- Diagnosis of breast, prostate, colorectal or gynaecological cancer.

- In follow-up phase with no further anti-cancer therapy planned.

Exclusion Criteria:

- Anti-cancer chemotherapy or radiotherapy within 4 weeks of trial entry.

- Evidence of sleep apnoea or other sleep disorder.

- Evidence of untreated major depressive disorder.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Colin Espie, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Glasgow

Authority:

United Kingdom: National Health Service

Study ID:

C8265/A3036

NCT ID:

NCT00134108

Start Date:

January 2003

Completion Date:

December 2005

Related Keywords:

  • Insomnia
  • Cancer
  • Sleep Initiation and Maintenance Disorders

Name

Location